Granite Investment Partners »

Ultragenyx Pharmaceutical shares owned by Granite Investment Partners

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Granite Investment Partners from 13F filings

Historical chart of Granite Investment Partners investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Granite Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Granite Investment Partners

Quarter filed Position value Share count Share price at filing
2025-03-31 $7.9M 217k 36.21
2024-12-31 $6.7M 160k 42.07
2024-09-30 $9.7M 175k 55.55

More positions owned by Granite Investment Partners

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Ge Aerospace Com New (GE)
Ge Vernova (GEV)
Eaton Corp SHS (ETN)
Visa Com Cl A (V)
Wintrust Financial Corporation (WTFC)
Rockwell Automation (ROK)
Tower Semiconductor Shs New (TSEM)
Meta Platforms Cl A (META)
Hubbell (HUBB)
S&p Global (SPGI)

View all positions for Granite Investment Partners

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
FMR
BlackRock
Jpmorgan Chase & Co
Sands Capital Management
State Street Corporation
Rtw Investments
Baker Bros. Advisors
Jacobs Levy Equity Management
Suvretta Capital Management
Wellington Management Company
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Bnp Paribas Investment Partners
Pictet Asset Management Holding SA

View all funds holding Ultragenyx Pharmaceutical